Form 4: Director Shelley Broader Receives RSU Grant at Inspire

Director Shelley G. Broader was granted 3,562 restricted stock units by Inspire Medical Systems, Inc.

Summary

• Director Shelley G. Broader acquired 3,562 restricted stock units (RSUs) on April 30, 2026.
• The RSUs represent a contingent right to receive one share of common stock per unit.
• Following this transaction, the reporting person holds a total of 8,471 shares of common stock.
• The grant was issued at a price of $0 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• The RSU grant aligns the director's interests with long-term shareholder value.

Negatives

• None identified.

Risks

• Vesting is subject to the reporting person's continued service with the issuer.

Future Outlook

The RSUs vest on the earlier of the first anniversary of the grant date or the date immediately prior to a Change of Control, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the medical device sector to ensure alignment with long-term strategic goals.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with compensation practices at peer medical technology companies like ResMed or LivaNova.
• The one-year vesting schedule is standard for director equity awards in the healthcare industry.

Stakeholder Impact

• Shareholders benefit from the alignment of director incentives with company performance.

Next Steps

• Vesting of the 3,562 RSUs on April 30, 2027, or upon a Change of Control.

Key Dates

Keywords

Inspire Medical Systems, INSP, Form 4, Insider Transaction, Restricted Stock Units, Shelley Broader